Profile ng asset
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the tre…
Pinakabago muna.
Ipinapakita ng Palatin ang Preclinical Data sa MC4R Agonist PL2001 sa ObesityWeek 2026
Iba pang gamot at kandidato ng parehong kumpanya na sinusubaybayan sa sektor na ito.